The Nicotine Justice Movement: Why the Fight for Smokers' Rights Is the Next Frontier of Health Equity

The nicotine justice movement does not have a single name, a single organization, or a single leader. It is not recognized by the public health establishment as a legitimate stakeholder in the nicotine policy debate. Its participants are the people whom the policies are designed to affect—smokers, vapers, nicotine pouch users, the consumers of all nicotine products—and its demand is simple: nothing about us without us. The movement argues that nicotine users have been systematically excluded from the policy processes that govern their behavior, that the policies designed without their input are less effective and less equitable than policies designed in partnership with them, and that the exclusion reflects a deeper pattern of stigma and paternalism that treats nicotine users as objects of intervention rather than citizens with rights. The nicotine justice movement is the most underappreciated development in the nicotine landscape—and it has the potential to transform the politics of nicotine policy in ways that both the industry and the public health establishment should be paying attention to.

The intellectual foundations of the nicotine justice movement draw from multiple traditions. The disability-rights movement provides the core principle: 'nothing about us without us'—the demand that people affected by policies have the right to participate in the design of those policies. The harm-reduction movement provides the ethical framework: the goal of policy should be to reduce harm, not to impose abstinence, and the people who use substances are the experts on their own experience. The patient-advocacy movement provides the organizational model: communities of people affected by a condition—HIV/AIDS, breast cancer, mental illness—organizing to demand a voice in research funding, treatment access, and policy decisions. The nicotine justice movement synthesizes these traditions into a specific demand: that nicotine users be recognized as a legitimate stakeholder community with the right to participate in the decisions that affect their lives. The demand is radical in the context of tobacco control—where nicotine users have historically been treated as the problem to be solved—but it is consistent with the broader trajectory of health justice movements that have transformed every other domain of health policy.

The nicotine justice movement faces structural obstacles that are more formidable than those faced by other health-justice movements. The stigma that attaches to nicotine use—particularly smoking—makes it difficult for nicotine users to organize publicly. The 'out and proud' strategy that was central to the HIV/AIDS and LGBT rights movements is not available to smokers, whose behavior is not just stigmatized but condemned as harmful to themselves and others. The economic marginalization of nicotine users—smoking is concentrated among the poor, the less-educated, and the mentally ill—makes it difficult to build an organization with the resources to sustain advocacy. The fragmentation of the nicotine-user community—smokers, vapers, pouch users, NRT users—along product lines and identity lines makes it difficult to build a unified political constituency. And the hostility of the public health establishment—which views consumer advocacy as industry-aligned or as a manifestation of addiction-distorted judgment—makes it difficult to gain legitimacy within the policy processes that the movement seeks to influence.

Despite these obstacles, the nicotine justice movement is growing. Consumer advocacy organizations—the New Nicotine Alliance (UK), the Smoke Free Alternatives Consumer Association (US), the International Network of Nicotine Consumer Organizations (global)—have established a presence in the policy debate, submitting testimony to regulatory agencies, participating in FCTC consultations, and building coalitions with harm reduction advocates and researchers. The organizations are small, underfunded, and largely volunteer-run—but they represent a constituency (nicotine users) that numbers in the hundreds of millions globally, and their claim to speak for that constituency is more direct than the claim of the tobacco control organizations that speak for 'the public interest' without including the affected public in their governance. The nicotine justice movement is not going to displace the traditional tobacco control establishment. But it is going to complicate the establishment's claim to represent the interests of the people it serves. The smokers who demand a voice in tobacco control policy, and who are told that their voices are invalid because they are smokers, are the people whom tobacco control claims to be helping. The contradiction is not sustainable.

The relationship between the nicotine justice movement and the tobacco industry is contested and complex. The industry has, in some cases, funded consumer advocacy organizations—a practice that invites the reasonable suspicion that the organizations are industry front groups rather than genuine consumer voices. The industry's interest in promoting consumer advocacy is transparent: a mobilized consumer constituency that opposes flavor bans and product restrictions is a political asset for an industry that opposes the same policies. But the alignment of interests between consumers and industry does not mean that consumer advocacy is industry-directed. The smokers who oppose flavor bans because they rely on flavored vaping products to stay off cigarettes are not doing the industry's bidding. They are pursuing their own interests, which happen to align with the industry's interests on this specific issue. The nicotine justice movement's challenge is to demonstrate its independence from industry while acknowledging that its interests sometimes overlap with industry interests—a challenge that is familiar to every consumer-advocacy movement that has navigated the tension between funding and independence.

The public health establishment's response to the nicotine justice movement will determine whether the movement becomes a constructive participant in the policy process or an adversarial opponent. The establishment can continue to dismiss consumer advocacy as industry-aligned and addiction-distorted—a response that will reinforce the movement's perception that the establishment is not interested in serving nicotine users but in controlling them. Or the establishment can engage with the movement as a legitimate stakeholder—acknowledging that nicotine users have perspectives and expertise that the policy process needs, creating mechanisms for consumer participation in regulatory decision-making, and treating the 'nothing about us without us' principle as applicable to nicotine policy. The second response is more difficult, more uncomfortable, and more consistent with the values that the public health establishment claims to uphold. The nicotine justice movement is a test of whether the public health establishment can extend the principles of participation and inclusion to the population it was created to serve—or whether those principles stop at the boundary of stigmatized behavior.

Shareable insight: A movement is emerging among nicotine consumers—smokers, vapers, pouch users—demanding a voice in the policies that govern their lives. 'Nothing about us without us' is the demand. The movement is small, underfunded, and dismissed by the public health establishment as industry-aligned. It is also morally compelling, consistent with the principles of every previous health-justice movement, and it represents a constituency of hundreds of millions. The public health establishment can engage with it—or it can continue to exclude the people it claims to serve.